Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: A propensity-matched study of multimorbidity in chronic heart failure

被引:23
|
作者
Ritchie, Christine [2 ]
Ekundayo, O. James
Muchimba, Maureen
Campbell, Ruth C.
Frank, Stuart J. [2 ]
Liu, Bo
Aban, Inmaculada B.
Ahmed, Ali [1 ,2 ]
机构
[1] Univ Alabama Birmingham, MPH, Birmingham, AL 35294 USA
[2] VA Med Ctr, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
Heart failure; Chronic kidney disease; Diabetes mellitus; Mortality; ACUTE MYOCARDIAL-INFARCTION; SCORE; MORTALITY; SYSTEM;
D O I
10.1016/j.ijcard.2008.12.089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic kidney disease (CKD) and diabetes mellitus (DM) are common comorbidities in heart failure (HF) and each is associated with poor outcomes. However, the effects of multimorbidity related to having both CKD and DM compared to CKD alone have not been well studied in a propensity-matched population of chronic HF patients. Methods: Of the 7788 ambulatory chronic HF patients in the Digitalis Investigation Group trial, 3527 had CKD, of whom 1095 had DM. Based on the absence or presence of DM, patients were categorized CKD-only and CKD-DM, respectively. Propensity scores for CKD-DM were calculated for each patient and were used to match 987 pairs of CKD-only and CKD-DM patients. Hazard ratios (HR) and 95% confidence intervals (CI) comparing CKD-DM patients with CKD-only patients were estimated using matched Cox regression models. Results: All-cause mortality occurred in 47.0% (rate, 1783/10,000 person-years of follow-up) of CKD-DM patients and 39.6% (rate, 1414/10,000 person-years) of CKD-only patients (HR when CKD-DM is compared with CKD-only, 1.25; 95% -CI, 1.07-1.46; p = 0.006). All-cause hospitalization occurred in 75.4% (rate, 5710/10,000 person-years) and 67.8% (rate, 4213/10,000 person-years) of CKD-DM and CKD-only patients respectively (HR, 1.32; 95% - CI, 1.15-1.52; p<0.0001). Respective HR and 95% - CI for other outcomes were: cardiovascular mortality (1.27; 1.06-1.52; p = 0.009), HF mortality (1.34; 1.04-1.72; p = 0.025); cardiovascular hospitalization (1.29; 1.12-1.49; p = 0.001) and HF hospitalization (1.37; 1.16-1.63; p<0.0001). Conclusions: Compared with comorbidity due to CKD alone, multimorbidity with CKD and DM was associated with poor outcomes in chronic HF patients. Published by Elsevier Ireland Ltd.
引用
收藏
页码:330 / 335
页数:6
相关论文
共 50 条
  • [41] Dialysis therapy and mortality in older adults with heart failure and advanced chronic kidney disease: A high-dimensional propensity-matched cohort study
    Zheng, Sijie
    Yang, Jingrong
    Tan, Thida C.
    Belani, Sharina
    Law, David
    Pravoverov, Leonid V.
    Kim, Susan S.
    Go, Alan S.
    PLOS ONE, 2022, 17 (01):
  • [42] Impact of new-onset diabetes mellitus and glycemic control on the prognosis of heart failure patients: A propensity-matched study in the community
    Romero, Sotero P.
    Garcia-Egido, Antonio
    Escobar, Miguel A.
    Andrey, Jose L.
    Corzo, Ramon
    Perez, Virginia
    Garcia-Domiguez, Gloria J.
    Gomez, Francisco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1206 - 1216
  • [43] Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community
    Romero, Sotero P.
    Andrey, Jose L.
    Garcia-Egido, Antonio
    Escobar, Miguel A.
    Perez, Virginia
    Corzo, Ramon
    Garcia-Domiguez, Gloria J.
    Gomez, Francisco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (02) : 404 - 412
  • [44] Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure
    Fishbane, Steven
    Miyawaki, Nobuyuki
    KIDNEY INTERNATIONAL, 2010, 77 (03) : 175 - 177
  • [45] Absence of interaction of diabetes mellitus with chronic kidney disease on mortality in acute heart failure
    de Miguel-Yanes, Jose M.
    Mendez-Bailon, Manuel
    Marco-Martinez, Javier
    Zapatero-Gaviria, Antonio
    Barba-Martin, Raquel
    RENAL FAILURE, 2014, 36 (10) : 1536 - 1540
  • [46] A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Boehm, Michael
    Gheorghiade, Mihai
    Kober, Lars
    Krum, Henry
    Maggioni, Aldo P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Zannad, Faiez
    Kim, So-Young
    Nowack, Christina
    Palombo, Giovanni
    Kolkhof, Peter
    Kimmeskamp-Kirschbaum, Nina
    Pieper, Alexander
    Pitt, Bertram
    EUROPEAN HEART JOURNAL, 2016, 37 (27) : 2105 - 2114
  • [47] Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease
    Cooper, Lauren B.
    Lippmann, Steven J.
    Greiner, Melissa A.
    Sharma, Abhinav
    Kelly, Jacob P.
    Fonarow, Gregg C.
    Yancy, Clyde W.
    Heidenreich, Paul A.
    Hernandez, Adrian F.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):
  • [48] Diuretic prescribing for patients with heart failure and chronic kidney disease in decompensated heart failure
    Ryan, D. K.
    Mandarano, L.
    Anderson, L.
    Jouhra, F.
    Banerjee, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 281 - 282
  • [49] Management of Heart Failure in Patients with Chronic Kidney Disease
    Ryan, David K.
    Banerjee, Debasish
    Jouhra, Fadi
    EUROPEAN CARDIOLOGY REVIEW, 2022, 17
  • [50] Chronic Kidney Disease in Hospitalized Patients with Heart Failure
    Nakamura, Satoko
    Anzai, Toshihisa
    Kawano, Yuhei
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S193 - S193